Emory Alzheimer's Disease Research Center
埃默里阿尔茨海默病研究中心
基本信息
- 批准号:10673933
- 负责人:
- 金额:$ 288.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-15 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:Academic Medical CentersAccelerationAction ResearchAddressAdvocateAffectAfrican AmericanAfrican American populationAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAreaAutopsyAwarenessBiological MarkersBiological Specimen BanksBloodBrainBrain imagingCaringClinicClinicalClinical ResearchClinical TrialsClinical Trials Support UnitCollaborationsCommunitiesComplementDNADataData ScientistDedicationsDementiaDevelopmentDiseaseDisparityEarly identificationEducationFacultyFamily CaregiverFosteringFoundationsFundingGeneticGoalsGrantHealth ProfessionalHeterogeneityImageIndividualIndividual DifferencesInstitutionInterventionLeadershipLinkMemoryOutcomeParticipantPathogenicityPersonal SatisfactionPilot ProjectsPlasmaPlayPreventionProteinsProteomicsPublic HealthPublicationsRaceRecommendationResearchResearch ActivityResearch PersonnelResearch SupportResourcesRiskRisk FactorsRoleSamplingScientistSpecial PopulationSpecimenSpinal CordTeacher Professional DevelopmentTrainingTranslatingTranslational ResearchTranslationsUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesVariantWorkbasebuilt environmentburden of illnesscaregivingcaregiving researchclinical practicecohortcommunity partnershipdata managementdesigndiversity and inclusioneducation researcheffective therapyempowermentethnoracialfaculty mentorhealthy agingimprovedinnovationmemory careminority engagementmultidisciplinaryneuropathologynext generationnoveloutreachprogramsrecruitresearch studyresponsesuccesssupportive environmentsymposiumtherapeutic targettraining opportunity
项目摘要
SUMMARY/ABSTRACT: OVERALL
The Goizueta Alzheimer’s Disease Research Center (ADRC) at Emory University provides Georgia and the
region with comprehensive clinical, research, and educational programs. This application outlines our success
in building an environment that encourages and supports innovative projects with a central theme of discovery
and translation of new biomarkers and pathogenic mechanisms to enable early identification, intervention, and
ultimately prevention of AD and related disorders. Given the well documented disparities in clinical research
participation and burden of disease for AD in the African American community, the Goizueta ADRC dedicates
effort and resources to help better understand and address inter-individual differences in AD and ADRD,
ranging from ethno-racial factors to individual differences in genetic and protein variation. We benefit from
generous institutional support from Emory, one of the nation’s fastest growing research academic medical
centers, the generous Atlanta community, and a large and highly collaborative interdisciplinary team of more
than 100 faculty across Emory and local institutions. Our cores work in a concerted manner to effectively
recruit, evaluate, and engage a diverse cohort of participants who actively take part in a wide variety of
research studies. The addition of a Minority Engagement Core helps to further engage special populations,
most notably the African American community, to help the Outreach, Recruitment and Engagement Core and
Clinical Core with an ambitious goal of 50% African American participation in the UDS cohort. Our Biomarker
Core provides state-of-the-art genetic, proteomic, and brain imaging analyses, complemented by an extensive
biospecimen repository of well-characterized blood, CSF, and DNA samples, and a large bank of well-
characterized postmortem brains and spinal cords in the Neuropathology Core. These valuable resources will
continue to be distributed widely for a variety of approved studies, including research Developmental Projects
and in support of local and national collaborations. Generous institutional and philanthropic support is used to
seed a much larger base of innovative research. The ADRC educational programs reach a broad audience of
trainees, researchers, health care professionals, and the public. New to us with this application, the Research
Education Component will help formalize our longstanding dedication to the cultivation of the next generation
of scientists. With a strong commitment to diversity and inclusiveness, our program benefits from the
engagement of a large and multidisciplinary core of training faculty mentors from institutions throughout the
greater Atlanta area. Collectively, the ADRC is poised to continue to make important contributions to the
national strategy for AD treatment and prevention.
摘要/摘要:总体
埃默里大学(Emory University)的Goizueta阿尔茨海默氏病研究中心(ADRC)提供了乔治亚州和佐治亚州和
具有全面的临床,研究和教育计划的地区。该应用程序概述了我们的成功
在建立一个鼓励和支持以发现中心主题的创新项目的环境中
以及新的生物标志物和致病机制的翻译,以实现早期鉴定,干预和
最终预防AD和相关疾病。鉴于临床研究中有据可查的分布
在非洲裔美国社区中,疾病的参与和燃烧,goizueta adrc dedicatedes
努力和资源以更好地理解和解决广告和ADRD的个体间差异,
从民族种族因素到遗传和蛋白质变异的个体差异范围。我们从中受益
埃默里(Emory)的慷慨机构支持,埃默里(Emory)是美国发展最快的研究学术医学之一
中心,慷慨的亚特兰大社区,以及一个大型,高度协作的跨学科团队
埃默里和地方机构的100名教职员工。我们的核心以协同的方式有效地工作
招募,评估和参与潜水员队列,他们积极参加各种各样的参与者
研究。增加少数派参与核心有助于进一步参与特殊人群,
最值得注意的是非裔美国人社区,以帮助外展,招聘和参与核心和
临床核心的目标是50%的非洲裔美国人参加UDS队列。我们的生物标志物
Core提供最先进的遗传,蛋白质组学和脑成像分析,由广泛完成
特征良好的血液,CSF和DNA样本的生物循环库以及一大批良好的库存库
在神经病理学核心中表征了事后大脑和脊髓。这些宝贵的资源将
继续为各种批准的研究(包括研究开发项目)进行广泛分发
并支持本地和国家合作。慷慨的机构和慈善支持用于
播种更大的创新研究基础。 ADRC教育计划吸引了广泛的受众
学员,研究人员,卫生保健专业人员和公众。通过此应用程序对我们来说是新的研究
教育部分将帮助我们长期以来对下一代培养的奉献精神
科学家。我们的计划对多样性和包容性做出了坚定的承诺,从
在整个机构的培训教师导师的大型和多学科的核心参与
大亚特兰大地区。总体而言,ADRC被中毒以继续为
国家广告治疗和预防战略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALLAN I LEVEY其他文献
ALLAN I LEVEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALLAN I LEVEY', 18)}}的其他基金
Novel Protein Biomarkers of Corticolimbic Pathophysiology in Lewy body Dementia
路易体痴呆皮质边缘病理生理学的新型蛋白质生物标志物
- 批准号:
10514142 - 财政年份:2022
- 资助金额:
$ 288.47万 - 项目类别:
Novel Protein Biomarkers of Corticolimbic Pathophysiology in Lewy body Dementia
路易体痴呆皮质边缘病理生理学的新型蛋白质生物标志物
- 批准号:
10704614 - 财政年份:2022
- 资助金额:
$ 288.47万 - 项目类别:
相似国自然基金
基于腔光机械效应的石墨烯光纤加速度计研究
- 批准号:62305039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于自持相干放大的高精度微腔光力加速度计研究
- 批准号:52305621
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
位移、加速度双控式自复位支撑-高层钢框架结构的抗震设计方法及韧性评估研究
- 批准号:52308484
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高离心加速度行星排滚针轴承多场耦合特性与保持架断裂失效机理研究
- 批准号:52305047
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于偏心光纤包层光栅的矢量振动加速度传感技术研究
- 批准号:62305269
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Center of Research Translation on Osteoporosis Bone Anabolic Therapies
骨质疏松症骨合成代谢疗法研究转化中心
- 批准号:
10404412 - 财政年份:2023
- 资助金额:
$ 288.47万 - 项目类别:
The Role of Thromboxane A2 in Vascular Regulation in Women with Endometriosis
血栓素 A2 在子宫内膜异位症女性血管调节中的作用
- 批准号:
10750782 - 财政年份:2023
- 资助金额:
$ 288.47万 - 项目类别:
Assessing Clinical Effectiveness and Implementation of Worksite Sleep Health Coaching in Firefighters
评估消防员工作现场睡眠健康指导的临床效果和实施情况
- 批准号:
10585123 - 财政年份:2023
- 资助金额:
$ 288.47万 - 项目类别:
New 5HT2AR Target Identification and Assay Development for Discovering Psychoplastogenic Compounds
用于发现精神质体化合物的新 5HT2AR 靶标鉴定和检测开发
- 批准号:
10742536 - 财政年份:2023
- 资助金额:
$ 288.47万 - 项目类别: